Novel hydrophilic taxane analogues inhibit growth of cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 2, 2012, Pages 563-567

  Fauzee, Nilufer Jasmine Selimah ^a   Wang, Ya Lan ^a   Dong, Zhi ^a   Li, Qian Ge ^a   Wang, Tao ^a   Mandarry, Muhammad Tasleem ^b   Lu, Xu ^a   Juan, Pan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Docetaxel; Growth; Paclitaxel; Taxol; Taxotere

Indexed keywords

ANTINEOPLASTIC AGENT; CQMU 0517; CQMU 0519; CQMU-0517; CQMU-0519; DOCETAXEL; DRUG DERIVATIVE; PACLITAXEL; TAXOID;

ARTICLE; BREAST TUMOR; CELL CYCLE; CELL PROLIFERATION; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG TUMOR; OVARY TUMOR; PATHOLOGY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LUNG NEOPLASMS; OVARIAN NEOPLASMS; PACLITAXEL; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 84866466913     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.2.563     Document Type: Article

References (33)

1. Bissery MC, Guénard D, Guéritte-Voegelein F, et al (1991). Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res, 51, 4845-52.
2. Calderoni A, Cerny T (2001). Taxanes in lung cancer: a review with focus on the European experience. Crit Rev Oncol Hematol, 38, 105-27.
3. Chang JT, Chang GC, Jiunn-Liang Ko, et al (2006). Induction of tubulin by Docetaxel is associated with p53 status in, human non small cell lung cancer cell lines. Int J Cancer, 118, 317-25.
4. Derry WB, Wilson L, Jordan MA (1995). Substoichiometric binding of taxol suppresses microtubule dynamics. Biochem, 34, 2203-11.
5. Fabbri F, Carloni S, Brigliadori G, et al (2006). Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric study. BMC Cell Biol, 7, 6.
6. Fauzee NJS, Dong Z, Wang YL (2011). Taxanes: promising anti-cancer drugs. Asian Pac J Cancer Prev, 12, 837-51
7. Ferlini C, Di Stefano M, Marone M, et al (1998) The synergistic anti-tumour activity of ICI 182,780 in combination with docetaxel is mediated by P-glycoprotein inhibition. Endocr Relat Canc, 5, 315-24.
8. Geng CX, Zeng ZC, Wang JY (2003). Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis. World J Gastroenterol, 9, 696-700.
9. Grant DS, Williams TL, Zahaczewsky M, et al (2003). Comparison of antiangiogenic activities using Paclitaxel (TAXOL) and Docetaxel (TAXOTERE). Int J Cancer, 104, 121-9.
10. Hennenfent KL, Govindan R (2006). Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol, 17, 735-49.
11. Ichite N, Chougule MB, Jackson T, et al (2009). Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res, 15, 543-52.
12. Jordan MA, Toso RJ, Thrower D, et al (1993). Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A, 90, 9552-6.
13. Jordan MA, Wendell K, Gardiner S et al (1996). Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res, 56, 816-25.
14. Jordan MA, Wilson L (1998). Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol, 10, 123-30.
15. Kang J, Wu X, Wang Z, et al (2010). Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors. J Ultrasound Med, 29, 61-70.
16. Katopodis O, Polyzos A, Kentepozidis N, et al (2010). Second line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial. Cancer Chemother Pharmaco, 67, 361-8.
17. Liebmann JE, Cook JA, Lipschultz C et al (1993). Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer, 68, 1104-9.
18. Mäenpäa JU(2003). Docetaxel: promising and novel combinations in ovarian cancer. Br J Cancer, 89, S29-34.
19. Mahaffey CM, Davies AM, Lara PN Jr, et al (2007). Schedule dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separation. Clin Lung Cancer, 8, 548-53.
20. Mhaidat NM, Zhang XD, ChenJiang C, et al (2007). Docetaxel- induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin Cancer Res, 13, 1308-14.
21. Mhaidat NM, Wang Y, Kiejda KA, et al (2007). Docetaxelinduced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther, 6, 752-61.
22. Nabell L, Spencer S (2003). Docetaxel with concurrent radiotherapy in head and neck cancer. Semin Oncol, 30, 89-93.
23. Nehmé A, Varadarajan P, Sellakumar G, et al (2001). Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells. Br J Cancer, 84, 1571-6.
24. Pectasides D, Pectasides M, Farmakis D, et al (2005). Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial. Ann Oncol, 16, 294-9.
25. Rao S, He L, Chakravarty S, et al (1999). Characterization of the taxol binding site on the microtubule. Identification of Arg282 in b-tubulin as the site of photoincorporation of a 7-benzophenone analogue of taxol. J Biol Chem, 274, 37990-4.
26. Schiff PB, Fant J, Horwitz SB (1979). Promotion of microtubule assembly in vitro by taxol. Nature, 277, 665-7.
27. Schiff PB, Horwitz SB (1980). Taxol stabilizes microtubules in mouse fibroblast cells. PNAS, 77, 1561-5.
28. Snyder JP, Nettles JH, Cornett B, et al (2001). The binding conformation of Taxol in b-tubulin: A model based on electron crystallographic density. Proc Natl Acad Sci U S A, 98, 5312-6.
29. Wani MC, Taylor HL, Wall ME, et al (1971). Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J AM Chem Soc, 93, 2325-7.
30. Wang QW, Lu HL, Song CC, et al (2005). Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel. World J Gastroenterol, 11, 4003-7.
31. Wang Z, Li M, Zhao W, Zhao G, et al (2007). Establishment and characterization of lung adenocarcinoma cell lines with multidrug resistance. Life Sci J, 4, 13-6.
32. Wenzel C, Steger GG (2006). Adjuvant treatment of breast cancer with taxanes. Breast Care, 1, 171-5.
33. Yvon AM, Wadsworth P, Jordan MA (1999). Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell, 10, 947-59.